BG102716A - Метод за лекуване на сърдечна недостатъчност със средства противодействащи на ендотелина - Google Patents

Метод за лекуване на сърдечна недостатъчност със средства противодействащи на ендотелина

Info

Publication number
BG102716A
BG102716A BG102716A BG10271698A BG102716A BG 102716 A BG102716 A BG 102716A BG 102716 A BG102716 A BG 102716A BG 10271698 A BG10271698 A BG 10271698A BG 102716 A BG102716 A BG 102716A
Authority
BG
Bulgaria
Prior art keywords
treatment
endotheline
formulations
opposing
cardiac insufficiency
Prior art date
Application number
BG102716A
Other languages
English (en)
Inventor
Joseph Lynch
You-Tang Shen
Original Assignee
Joseph Lynch
You-Tang Shen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Joseph Lynch, You-Tang Shen filed Critical Joseph Lynch
Publication of BG102716A publication Critical patent/BG102716A/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Materials For Photolithography (AREA)
  • Photosensitive Polymer And Photoresist Processing (AREA)

Abstract

Изобретението се използва за предотвратяване и/или лечение на сърдечна недостатъчност. То се отнасядо съединения, които се противопоставят на ендотелина.
BG102716A 1996-04-04 1998-08-21 Метод за лекуване на сърдечна недостатъчност със средства противодействащи на ендотелина BG102716A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1488296P 1996-04-04 1996-04-04
PCT/US1997/003737 WO1997037665A1 (en) 1996-04-04 1997-03-19 Method of treating heart failure with endothelin antagonists

Publications (1)

Publication Number Publication Date
BG102716A true BG102716A (bg) 1999-09-30

Family

ID=21768326

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102716A BG102716A (bg) 1996-04-04 1998-08-21 Метод за лекуване на сърдечна недостатъчност със средства противодействащи на ендотелина

Country Status (25)

Country Link
US (3) US5834483A (bg)
EP (1) EP0906108B1 (bg)
JP (2) JP3345891B2 (bg)
KR (1) KR20000005178A (bg)
CN (1) CN1215335A (bg)
AT (1) ATE297739T1 (bg)
AU (1) AU723351B2 (bg)
BG (1) BG102716A (bg)
BR (1) BR9708525A (bg)
CA (1) CA2249330C (bg)
CZ (1) CZ296098A3 (bg)
DE (1) DE69733557T2 (bg)
EA (1) EA003587B1 (bg)
EE (1) EE9800315A (bg)
ES (1) ES2241047T3 (bg)
HU (1) HUP9903893A3 (bg)
IL (1) IL126175A (bg)
IS (1) IS4847A (bg)
NO (1) NO984564L (bg)
NZ (1) NZ331789A (bg)
PL (1) PL329077A1 (bg)
SK (1) SK130098A3 (bg)
TR (1) TR199801988T2 (bg)
UA (1) UA50761C2 (bg)
WO (1) WO1997037665A1 (bg)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE9800315A (et) * 1996-04-04 1999-06-15 Banyu Pharmaceutical Co., Ltd. Meetod südamepuudulikkuse käitlemiseks endoteliini antagonistide abil
AU711936B2 (en) * 1996-08-09 1999-10-28 Banyu Pharmaceutical Co., Ltd. Stereoselective deoxygenation reaction
DE69914880T2 (de) 1998-01-21 2004-08-05 Banyu Pharmaceutical Co., Ltd. Substituierte 5-(2,2difluor-1,3-benzodioxol-5-yl) cyclopentenopyridinderivate
US8168616B1 (en) 2000-11-17 2012-05-01 Novartis Ag Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
EP1577310A1 (en) * 2002-12-27 2005-09-21 Kaneka Corporation Processes for producing optically active 2-thiomethyl-3-phenylpropionic acid derivative and for producing intermediate therefor
MXPA06005518A (es) 2003-11-17 2006-08-17 Novartis Ag Uso de inhibidores de la dipeptidil peptidasa iv.
GB0327839D0 (en) 2003-12-01 2003-12-31 Novartis Ag Organic compounds
BRPI0508880A (pt) 2004-03-17 2007-09-04 Novartis Ag uso de compostos orgánicos
US20100040666A1 (en) 2005-06-24 2010-02-18 Hiroshi Azuma Method for Control of Drug Elution Rate and Composition for Coating of Drug-Eluting Stent
AR080683A1 (es) 2010-03-16 2012-05-02 Novartis Ag Composiciones farmaceuticas de aliskiren y metodos de administracion

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4971959A (en) * 1987-04-14 1990-11-20 Warner-Lambert Company Trisubstituted phenyl analogs having activity for congestive heart failure
GB9007762D0 (en) * 1990-04-05 1990-06-06 Beecham Group Plc Novel compounds
US5565485A (en) * 1993-03-19 1996-10-15 Merck & Co., Inc. Biphenyl compounds useful or endothelin antagonists
DK0699069T3 (da) 1993-04-27 2002-05-27 Smithkline Beecham Corp Endothelinreceptorantagonister
US5571813A (en) * 1993-06-10 1996-11-05 Beiersdorf-Lilly Gmbh Fused pyrimidine compounds and their use as pharmaceuticals
DE69426698T2 (de) * 1993-08-18 2001-08-16 Banyu Pharmaceutical Co., Ltd. Kondensierte heteroaromatische cyclopentenderivate mit endothelin-antagonistischer aktivität
US5389620A (en) * 1993-08-18 1995-02-14 Banyu Pharmaceutical Co., Ltd. Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives
US5658943A (en) * 1995-01-05 1997-08-19 Warner-Lambert Company Phenylalanine derivatives as endothelin antagonists
EE9800315A (et) * 1996-04-04 1999-06-15 Banyu Pharmaceutical Co., Ltd. Meetod südamepuudulikkuse käitlemiseks endoteliini antagonistide abil

Also Published As

Publication number Publication date
ES2241047T3 (es) 2005-10-16
CN1215335A (zh) 1999-04-28
IL126175A0 (en) 1999-05-09
US5834483A (en) 1998-11-10
EP0906108A1 (en) 1999-04-07
CA2249330C (en) 2005-08-09
KR20000005178A (ko) 2000-01-25
TR199801988T2 (xx) 2000-08-21
ATE297739T1 (de) 2005-07-15
PL329077A1 (en) 1999-03-15
BR9708525A (pt) 1999-08-03
HUP9903893A3 (en) 2001-05-28
JP2000510824A (ja) 2000-08-22
NO984564D0 (no) 1998-09-30
EA199800889A1 (ru) 1999-04-29
US6380195B1 (en) 2002-04-30
NO984564L (no) 1998-12-04
EA003587B1 (ru) 2003-06-26
IS4847A (is) 1998-09-15
UA50761C2 (uk) 2002-11-15
DE69733557T2 (de) 2005-11-03
DE69733557D1 (de) 2005-07-21
SK130098A3 (en) 1999-05-07
CA2249330A1 (en) 1997-10-16
US6087360A (en) 2000-07-11
EE9800315A (et) 1999-06-15
AU723351B2 (en) 2000-08-24
HUP9903893A2 (hu) 2001-04-28
AU2202597A (en) 1997-10-29
IL126175A (en) 2003-05-29
WO1997037665A1 (en) 1997-10-16
EP0906108A4 (en) 2000-12-06
NZ331789A (en) 2000-05-26
JP3345891B2 (ja) 2002-11-18
EP0906108B1 (en) 2005-06-15
CZ296098A3 (cs) 1999-06-16
JP2002220337A (ja) 2002-08-09

Similar Documents

Publication Publication Date Title
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
MY117032A (en) A novel compound form.
IL110943A0 (en) Compositions for the treatment of skin disorders
IL121170A0 (en) Compositions for the treatment of dermatological disorders
HUP9903166A3 (en) Medicinal compositions for the prophylaxis or treatment of arteriosclerosis
FI941826A7 (fi) Menetelmät ja koostumukset elimen hypofunktion ennaltaehkäisemiseksi ja/tai terapeuttiseksi hoitamiseksi
ZA943744B (en) Therapeutic substituted guanidines
AU2160492A (en) Treatment of human diseases involving dysregulation or dysfunction of the nervous system
GB8900678D0 (en) Compositions for the prevention and medical treatment of parodonthopathy
BG102818A (bg) D-манитол и метод за неговото получаване
UA41355C2 (uk) Засіб для лікування нейро-сніду
GB2311940B (en) Pharmaceutical compositions for the treatment of rhinitis
BG102716A (bg) Метод за лекуване на сърдечна недостатъчност със средства противодействащи на ендотелина
ZA977310B (en) Transdermal propentofylline compositions for the treatment of Alzheimer's disease.
MXPA94009086A (es) Guanidinas sustituidas terapeuticas.
IN167848B (bg)
BG102667A (bg) Състав, съдържащ диосгенин
IL111805A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of aphthae
IE821855L (en) Glycerophosphocholines
IL113057A0 (en) Compositions for the treatment of dandruff
DE59104412D1 (de) Dynamische Redressionsschiene zur Therapie der Vorfussadduktion.
GB9510162D0 (en) Compositions for the treatment of skin conditions
ZA949564B (en) Method for treating constipation using dimeticone.
IL124576A0 (en) Compositions and methods for the prevention and treatment of oral mucositis